Jun 18, 2026 12:35PM
Jun 18, 2026 12:35PM
Jun 18, 2026 07:00AM
Jun 18, 2026 07:00AM
Jun 16, 2026 03:22PM
Jun 16, 2026 10:18AM
Jun 12, 2026 07:30AM CervoMed to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit
Jun 10, 2026 07:30AM
Jun 10, 2026 07:30AM
May 18, 2026 07:30AM
Apr 22, 2026 07:30AM
Apr 7, 2026 07:30AM
Apr 7, 2026 07:30AM
Mar 19, 2026 07:31AM CervoMed shares new data showing drug benefits for dementia patients
Mar 19, 2026 07:30AM
Mar 17, 2026 07:30AM
Mar 12, 2026 07:00AM
Mar 4, 2026 07:30AM
Mar 4, 2026 07:30AM
Feb 18, 2026 06:02AM
Feb 18, 2026 06:00AM CervoMed’s neflamapimod elected for inclusion in UK EXPERTS-ALS platform designed to prioritize promising treatments for Amyotrophic Lateral Sclerosis
Dec 4, 2025 05:00PM
Dec 4, 2025 05:00PM
Dec 2, 2025 07:01AM
Dec 2, 2025 07:00AM
Nov 24, 2025 07:00AM
Nov 10, 2025 07:00AM
Nov 4, 2025 07:00AM CervoMed gains FDA alignment for dementia with Lewy bodies drug trial
Nov 4, 2025 07:00AM
Oct 28, 2025 08:03AM
Oct 28, 2025 08:00AM
Oct 8, 2025 07:00AM
Oct 8, 2025 07:00AM
Oct 7, 2025 08:01AM
Oct 7, 2025 08:00AM CervoMed Appoints Matthew Winton, Ph.D., as Chief Commercial and Business Officer
Sep 17, 2025 07:30AM
Aug 11, 2025 08:00AM
Jul 28, 2025 07:01AM
Jul 28, 2025 07:00AM
Jun 10, 2025 08:00AM
May 12, 2025 03:57PM
May 12, 2025 08:00AM CervoMed Reports First Quarter 2025 Financial Results and Provides Corporate Updates
Apr 2, 2025 07:00AM
Mar 17, 2025 08:00AM
Mar 11, 2025 08:20AM
Mar 10, 2025 04:05PM
Jan 31, 2025 08:03AM
Jan 31, 2025 08:00AM
Dec 12, 2024 07:00AM CervoMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dec 10, 2024 07:02AM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All